This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Novartis Ag. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: The Innovations of Andrew Anh Nguyen
Introduction
Andrew Anh Nguyen is an accomplished inventor based in Brookline, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has the potential to impact various therapeutic applications.
Latest Patents
Andrew Anh Nguyen holds a patent for "Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules." This patent provides anti-BTC antibodies, methods of producing these antibodies, pharmaceutical compositions comprising these antibodies, and methods of using them. Additionally, it includes multi-specific binding molecules, such as bispecific antibodies, which comprise a BTC binding moiety and an anti-VEGF binding moiety.
Career Highlights
Andrew is currently associated with Novartis AG, a leading global healthcare company. His role involves research and development in innovative therapeutic solutions. His expertise in antibody technology has positioned him as a valuable asset in the field.
Collaborations
Andrew has collaborated with notable colleagues, including Chad Eric Bigelow and Ana Maria Carrion. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Andrew Anh Nguyen's contributions to biotechnology through his patent and work at Novartis AG exemplify the impact of innovative thinking in the medical field. His advancements in antibody technology are paving the way for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile